NCT06758752View on ClinicalTrials.gov

A Herbal Compound for Eczema

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

December 30, 2026

Study Completion Date

December 30, 2026

Conditions
EczemaAtopic DermatitisInflammation
Interventions
DIETARY_SUPPLEMENT

ZAX.1400.EC.02

ZAX.1400.EC.02, applied twice daily for 3 weeks after enrolment

DRUG

Placebo

Placebo, applied twice daily for 3 weeks after enrolment

Trial Locations (1)

7461686688

Fasa university of medical sciences, Fasa

Sponsors

Collaborators (1)

Herbmedx Co
All Listed Sponsors
collaborator

Herbmedx Co

INDUSTRY

collaborator

Zarrin Avaye Kowsar Salamat (ZAX company)

UNKNOWN

lead

Fasa University of Medical Sciences

OTHER

NCT06758752 - A Herbal Compound for Eczema | Biotech Hunter | Biotech Hunter